Patents. Law. Pharma.

Quoted - Data shows USPTO treating IPR, PGR discretionary denials differently
July 9, 2025, IAM Media, See Publication

Quoted - New Version of Merck’s Blockbuster Cancer Drug Threatened by Patent Battle
March 5, 2025, The Wall Street Journal, See Publication

Quoted - The Broad won the biggest CRISPR patent fight yet, but the rivalry over gene editing is still simmering
April 4, 2022, The Boston Globe, See Publication

The Hudson Institute Memo Draws the Wrong Conclusions From Discrepancies in I-MAK's Data
March 23, 2022, IPWatchdog, See Publication

Quoted - Alnylam sues Moderna and Pfizer over key COVID vaccine ingredient
March 22, 2022, The Boston Globe, See Publication

Quoted — U.S. Backs Waiver of Intellectual Property Protection for Covid-19 Vaccines
May 5, 2021, The Wall Street Journal, See Publication

Quoted — How Much Trouble is Lil Nas X in With the Nike Satan Shoe Lawsuit?
March 30, 2021, Vice, See Publication

Quoted — The key ingredient that could hold back vaccine manufacturing
March 3, 2021, Vox/Recode, See Publication

Quoted — Fed. Circ. Ruling May Reshape Hatch-Waxman Litigation Map
November 17, 2020, Law360 — Intellectual Property, See Publication

Quoted — PTAB Decision May Force Changes For Patent Challenge Groups
October 8, 2020, Bloomberg Law, See Publication

Quoted — Moderna Loses Key Patent Challenge, Puts COVID-19 Vaccine at Risk
July 27, 2020, FDANews, See Publication

Quoted — Moderna loses challenge to Arbutus patent on vaccine technology
July 23, 2020, Reuters, See Publication

Speaker — Cantor Fitzgerald Analyst/Industry Discussion: $AMRN Vascepa Patent Litigation
June 29, 2020, Cantor Fitzgerald, See Video

Quoted — 4 Takeaways As AbbVie Crushes ‘Patent Thicket’ Litigation
June 12, 2020, Law360 - Intellectual Property, See Publication

Speaker — Cantor Fitzgerald Analyst/Industry Discussion: $AMRN Vascepa Patent Litigation
May 21, 2020, Cantor Fitzgerald, See Video

Quoted — Government May Have Ownership or Rights to Coronavirus Vaccines
March 20, 2020, Bloomberg Law, See Publication

Quoted — Intel, Apple Using Antitrust as New Weapon in Patent Fights
March 5, 2020, Bloomberg Law, See Publication

Quoted — Sanofi Ruling Makes Getting Drugs on FDA Approved List Trickier
February 14, 2020, Bloomberg Law, See Publication

Quoted — Nike vs. Skechers: What’s at Stake in Their Contentious Legal Battle
October 31, 2019, Footwear News, See Publication

Quoted - Merck’s Patent Loss to Gilead May Have Big Impact on Drugmakers
October 31, 2019, Bloomberg Law, See Publication

Downstream Customers Will Face Increased Patent Suit Risk
October 30, 2019, Law360 - Intellectual Property, See Publication

Quoted - AbbVie/Allergan: Biopharma Tie-up Draws FTC Exclusionary Bundling Questions 
August 28, 2019, The Capital Forum, Vol. 7 No. 314

Quoted - How To Get the Most Out of an Expert Witness
August 2, 2019, Law360 - Intellectual Property, See Publication

The Pathway to Foreign Damages for Patent Infringement
June 7, 2019, IPWatchdog, See Publication

Quoted - 'Groundbreaking' AbbVie Suits Test Bold Anti-Generic Tactics
March 27, 2019, Law360 - Intellectual Property, See Publication

District of Delaware Makes It Harder To Corner The Market On Antibody Patents In MorphoSys v. Janssen
January 31, 2019, IPWatchdog, See Publication

Quoted - Should You Opt for a Career Expert Witness or a First Timer?
January 29, 2019, Best Lawyers, See Publication

Quoted - Genmab, J&J prevail in patent dispute with Morphosys
January 29, 2019, BioWorld, See Publication

Quoted - Look out, AbbVie. Thanks to Boehringer, your Humira biosimilar defense isn't over yet
September 13, 2018, FiercePharma, See Publication

Quoted - University of California's first CRISPR patent win
August 6, 2018, Nature Biotechnology 36, 673 (2018), See Publication 

Quoted - Fed. Cir. Tribal Ruling Puts State PTAB Immunity In Doubt
July 23, 2018, Law 360 - Intellectual Property, See Publication

Quoted - Huawei patent case shows Chinese courts' rising clout
June 11, 2018, Reuters, See Publication

Quoted - Getting Juries To Ax Patents Under Alice May Be Hard Sell
Mar 5, 2018, Law 360 - Intellectual Property, See Publication

Celgene’s New Revlimid® Lawsuits Shows Shifting Tactics From Earlier Natco Case
Nov 21, 2017, IPWatchdog, See Publication

Did the Federal Circuit doom Amgen’s Enbrel® monopoly?
Nov 10, 2017, IPWatchdog, See Publication

Quoted -- Allergan’s Mohawk evergreening patent deal draws criticism, but ultimately may flop
Nov 9, 2017, Nature Biotechnology, (Vo. 35 No. 11 p. 1002), See Publication

Quoted -- Restasis Ruling Could Be Bad Sign For Tribal Patent Pacts
Oct 17, 2017, Law360 - Intellectual Property, See Publication

Quoted -- U.S. court reverses ban on sale of Regeneron, Sanofi cholesterol drug
Oct 5, 2018, Reuters, See Publication

Quoted -- AbbVie, Amgen Reach Settlement in Humira Patent Dispute
Sep 28, 2017, The Wall Street Journal, See Publication

Quoted -- Things To Consider Before A Patent Deal With A Tribe
 Sep 27, 2017, Law360 - Intellectual Property, See Publication

The biggest problem with Allergan’s St Regis Mohawk deal is that the tribe may not own the patents
Sep 18, 2018, IAM Blog, See Publication

Even if IPRs are deemed unconstitutional, not much will change - except for pharma sector, which will hate it
Jun 23, 2017, IAM Blog, See Publication

IPR Oral Argument Rules Offer Opportunities, Pitfalls
Jun 22, 2017, Law 360 - Intellectual Property, See Publication

Is TC Heartland All Good News for Patent Litigation Defendants?
Jun 7, 2017, IPWatchdog, See Publication

Quoted - Regeneron, Sanofi urge court to reverse ban on cholesterol drug
Jun 6, 2017, Reuters, See Publication

Amgen v. Regeneron: Will the permanent injunction against Regeneron’s new PCSK9-inhibitor hold up on appeal?
Jan 17, 2017, IPWatchdog, See Publication

Quoted -- Going Mainstream: Will Blockchain's Open-Source Ethos Survive Corporate America?
Oct 16, 2016, Law 360 - In Depth, See Publication

After the CAFC's Planet Blue decision early Alice motions may now fade away
Sep 16, 2016, IAM Media, See Publication

Quoted - Automobile technology sector seen as target of possible patent war
Apr 28, 2016, The Patent Investor, See Publication

Quoted - Janssen Biotech requests expedited trial in Remicade patent dispute with Celltrion
Apr 14, 2016, The Patent Investor, See Publication

Quoted - Patent investors are pursuing trading strategy around patent disputes over biologics
Mar 31, 2016, The Patent Investor, See Publication

Quoted - Panel Recommends FDA Approval of Remicade Knockoff
Feb 9, 2016, The Wall Street Journal, See Publication

McRo decision expected to clarify abstract idea doctrine under Alice
Jan 5, 2016, IPWatchdog, See Publication

Big pharma scores first victory in IPR battle with Bass and Spangenberg, but the war is far from over
Aug 27, 2015, IAM Media, See Publication

The Kyle Bass pharma patent IPR strategy looks to be a lot more sophisticated and long-term than many think
Jul 17, 2015, IAM Media, See Publication

Inter-Partes Review: America’s Patent Litigation Game-Changer
Nov 2014, The Patent Lawyer Magazine